Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VRTX
VRTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VRTX News
Vertex and Mirum Pharmaceuticals Market Dynamics
16h ago
NASDAQ.COM
Vertex and Mirum: Biotech Investment Opportunities
17h ago
Fool
Vertex Pharmaceuticals Target Price Raised to $612 by Morgan Stanley
2d ago
Yahoo Finance
Vertex Pharmaceuticals Stock Performance Strong
2d ago
CNBC
Vertex Pharmaceuticals Faces Challenges in Cystic Fibrosis Market Dominance
3d ago
Fool
Vertex Pharmaceuticals Faces Competitive Threats
3d ago
NASDAQ.COM
Soaring Gas Prices Raise Inflation Concerns in the U.S.
5d ago
Fool
NextEra Energy's Optimistic Outlook Amid Inflation Concerns
5d ago
NASDAQ.COM
Morgan Stanley Raises Vertex Price Target to $612
Apr 11 2026
Yahoo Finance
Avaí Bio Advances Cell Therapy for Aging
Apr 10 2026
PRnewswire
Avaí Bio and Austrianova Advance Anti-Aging Therapy Collaboration
Apr 10 2026
Newsfilter
Halozyme and Vertex Enter Exclusive Licensing Agreement
Apr 07 2026
seekingalpha
CRISPR Therapeutics Faces Significant Challenges Ahead
Apr 07 2026
NASDAQ.COM
CRISPR Therapeutics Faces Challenges and Opportunities
Apr 07 2026
Fool
Vertex Pharmaceuticals Receives FDA Approval for Label Expansions of Alyftrek and Trikafta
Apr 01 2026
seekingalpha
Vertex Expands ALYFTREK and TRIKAFTA Indications, Benefiting 800 New CF Patients
Apr 01 2026
Newsfilter
Show More News
